Patin, Emmanuel C. http://orcid.org/0000-0001-5390-5733
Nenclares, Pablo http://orcid.org/0000-0002-1750-3179
Chan Wah Hak, Charleen http://orcid.org/0000-0002-6386-5699
Dillon, Magnus T. http://orcid.org/0000-0001-5136-5227
Patrikeev, Anton
McLaughlin, Martin
Grove, Lorna
Foo, Shane http://orcid.org/0000-0001-6295-7404
Soliman, Heba
Barata, Joao P. http://orcid.org/0009-0008-6179-391X
Marsden, Joanna
Baldock, Holly
Gkantalis, Jim
Roulstone, Victoria
Kyula, Joan
Burley, Amy http://orcid.org/0000-0003-3074-6439
Hubbard, Lisa
Pedersen, Malin
Smith, Simon A. http://orcid.org/0000-0002-3591-3016
Clancy-Thompson, Eleanor
Melcher, Alan A. http://orcid.org/0000-0002-2042-3380
Ono, Masahiro http://orcid.org/0000-0002-9284-7326
Rullan, Antonio http://orcid.org/0000-0002-7365-9629
Harrington, Kevin J. http://orcid.org/0000-0002-6014-348X
Funding for this research was provided by:
Rosetrees Trust (CM48 and CM444)
Cancer Research UK (C7224/A23275)
Article History
Received: 5 January 2024
Accepted: 19 July 2024
First Online: 13 August 2024
Competing interests
: E.C. and S.A.S. are employees and stockholders of AstraZeneca. The remaining authors declare no competing interests.